Duloxetine
Aliases: Cymbalta
Summary
Duloxetine is a dual serotonin and norepinephrine reuptake inhibitor.[label] It was originally discovered in 1993 and developed by Eli Lilly and Company as LY248686. Duloxetine first received approval from the FDA in August, 2004 as Cymbalta for the treatment of Major Depressive Disorder.
Effects
Aggregated from 15 Erowid experience reports
Positive Effects 5
Stimulation
33.3%
70%
Focus Enhancement
20.0%
70%
Euphoria
20.0%
70%
Body High
20.0%
70%
Empathy
20.0%
70%
Adverse Effects 3
Anxiety
60.0%
70%
Nausea
26.7%
70%
Confusion
20.0%
70%
Pill Identifiers
4
known pill identifiers on record — view imprints, colors, shapes, and images
→
Duloxetine's nerd page
Pharmacology, chemical data, effect profiles, and more
→